The social and economic burden of frontotemporal degeneration

Conclusions:
The economic burden of FTD is substantial. Counting productivity-related costs, per-patient costs for FTD appear to be greater than per-patient costs reported for AD. There is a need for biomarkers for accurate and timely diagnosis, effective treatments, and services to reduce this socioeconomic burden.

Source: Neurology - November 13, 2017 Category: Neurology Authors: Galvin, J. E., Howard, D. H., Denny, S. S., Dickinson, S., Tatton, N. Tags: Cost effectiveness/economic, Quality of life, All Cognitive Disorders/Dementia, Frontotemporal dementia ARTICLE Source Type: research